VCCC Annual Report 2018-19
This year's triumph has been bringing to life the innovative, game-changing programs that make up the VCCC Strategic Research Plan 2017-20.
The VCCC and MPCCC has developed a joint initiative to provide support and advice to clinicians and health care services treating patients with cancer during the COVID-19 pandemic.
The Victorian COVID-19 Cancer Network collaborates on a digital platform for professional discussion, information and support, as the pandemic progresses.
Events and seminars are now being conducted online where possible.
You can also catch up on previous seminars via the Open Learning platform.
Peter Mac is Australia’s only integrated cancer research, treatment and education centre, with multidisciplinary teams that provide care informed by precision in fundamental, translational and clinical research.
The Royal Melbourne Hospital (Melbourne Health) provides high-quality cancer treatment programs, translational research, and surgical and medical expertise, as well as other key support services such as clinical care and emergency medicine.
Australia’s first ranked research university and medical school, the university provides academic and research expertise to the alliance.
The Women’s provides specialist cancer services for women with breast and gynecological cancer and conducts research into the treatment and care of women with cancer, as well as the specific impacts of gender on cancer.
The Walter and Eliza Hall Institute is one of Australia’s leading biomedical research organisations, with a strong national and international reputation for performing highly influential basic and translational research.
The Children’s Cancer Centre is the only provider of complex children’s cancer care and stem cell transplantation in Victoria and is a leader in the research and treatment of childhood cancer.
Western Health is the largest provider of treatment for colorectal cancer and a leader in the treatment of upper gastro-intestinal cancers with programs in breast, lung, genitourinary, gynaecology and haematological cancer.
Western Health has on-site radiation therapy and chemotherapy facilities and has a strong palliative care service.
A leader in palliative care practice and complex cancer surgery, St Vincent’s Hospital Melbourne also provides oncology and haematology services, on-site radiation therapy and chemotherapy facilities, in addition the hospital houses the Victorian-wide psycho-oncology service.
The hospital shares its campus with St Vincent's Institute, which has fundamental and clinical researchers working on mechanisms of cancer and diseases of cancer survivorship.
The Olivia Newton-John Cancer Wellness & Research Centre at Austin Health provides world-leading specialist treatment and holistic care including clinical trials both independently and in partnership with the Olivia Newton-John Cancer Research Institute (ONJCRI) – a leader in the development of experimental and breakthrough cancer treatments only metres from where patients are cared for.
The MCRI is a leader in understanding the underlying mechanisms and treatment of paediatric cancer and is home to the Children’s Cancer Tissue bank; a world class resource for researchers studying rare solid tumours and leukemia.
Peter Mac is Australia’s only integrated cancer research, treatment and education centre, with multidisciplinary teams that provide care informed by precision in fundamental, translational and clinical research.
The Royal Melbourne Hospital (Melbourne Health) provides high-quality cancer treatment programs, translational research, and surgical and medical expertise, as well as other key support services such as clinical care and emergency medicine.
Australia’s first ranked research university and medical school, the university provides academic and research expertise to the alliance.
The Women’s provides specialist cancer services for women with breast and gynecological cancer and conducts research into the treatment and care of women with cancer, as well as the specific impacts of gender on cancer.
The Walter and Eliza Hall Institute is one of Australia’s leading biomedical research organisations, with a strong national and international reputation for performing highly influential basic and translational research.
The Children’s Cancer Centre is the only provider of complex children’s cancer care and stem cell transplantation in Victoria and is a leader in the research and treatment of childhood cancer.
Western Health is the largest provider of treatment for colorectal cancer and a leader in the treatment of upper gastro-intestinal cancers with programs in breast, lung, genitourinary, gynaecology and haematological cancer.
Western Health has on-site radiation therapy and chemotherapy facilities and has a strong palliative care service.
A leader in palliative care practice and complex cancer surgery, St Vincent’s Hospital Melbourne also provides oncology and haematology services, on-site radiation therapy and chemotherapy facilities, in addition the hospital houses the Victorian-wide psycho-oncology service.
The hospital shares its campus with St Vincent's Institute, which has fundamental and clinical researchers working on mechanisms of cancer and diseases of cancer survivorship.
The Olivia Newton-John Cancer Wellness & Research Centre at Austin Health provides world-leading specialist treatment and holistic care including clinical trials both independently and in partnership with the Olivia Newton-John Cancer Research Institute (ONJCRI) – a leader in the development of experimental and breakthrough cancer treatments only metres from where patients are cared for.
The MCRI is a leader in understanding the underlying mechanisms and treatment of paediatric cancer and is home to the Children’s Cancer Tissue bank; a world class resource for researchers studying rare solid tumours and leukemia.
In last month’s message I remarked on the breadth of Medical Research Future Fund (MRFF) and National Health and Medical Research Council (NHMRC) funding across the VCCC alliance for some of Australia’s big cancers.
This month, further funding has been announced that is consistent with our goal to speed up translation of cancer biology to 21st century personalised cancer care, prioritise new technologies and improve outcomes for people with cancers that have lower survival rates.
Three talented researchers to receive $10,000 each to extend their research and develop global collaborations
Each year, the VCCC invites PhD students to apply for a prestigious award in the categories of basic science, clinical science and population health. The Picchi Award for Excellence in Cancer Research prizes are awarded in a tradition that has spanned more than a decade, and acknowledge potential world-class researchers embarking on their careers.
Breast cancer patient care requires the expertise of a wide range of specialists. To create better, more effective multidisciplinary teams (MDTs) the VCCC is launching a multidisciplinary medical education series for breast cancer.
Monthly sessions will focus on key issues in breast cancer management, including areas where there is recent change and uncertainty, and where multidisciplinary decision-making is essential for optimal patient care.
Earlier this year, the Australian Government awarded $32 million to MTPConnect for the Researcher Exchange and Development within Industry (REDI) initiative, through the Medical Research Future Fund.
To deliver the REDI program MTPConnect has partnered with research, training and industry organisations, including the Victorian Comprehensive Cancer Centre (VCCC) to implement an integrated plan driving skills development and workforce training to enhance the medical technologies and pharmaceutical industry.
Dr Kym Jenkins is Chair of the Council of Presidents of Medical Colleges, immediate past-President of the Royal Australian New Zealand College of Psychiatrists (RANZCP), Chair of the Migrant and Refugee Health Partnership and Board Director at Mental Health Australia.
In March this year my colleagues Karen Gaunson, Margie Stuchbery, Brett McDermott and I joined together to work out how we, as a group of experienced mental health clinicians, could best contribute during the COVID-19 pandemic.
The current COVID-19 pandemic raises critical clinical questions and challenges for health professionals seeking to continue optimal care for patients with cancer. Monash Partners Comprehensive Cancer Consortium (MPCCC) and the VCCC present our next special Cancer and COVID event.
Showcasing the latest exciting developments in basic, translational and clinical research and will provide opportunities to develop collaborations among Victorian institutes.
All are welcome to an online meeting showcasing the latest developments in breast cancer-related research locally, nationally and globally.
Join us to hear from postdoctoral fellow, Dr Raymond Yip, present on Quantitative 3D imaging of vascular niches for disseminated mammary tumour cells in bone marrow.
The Monash Partners Comprehensive Cancer Consortium (MPCCC) will recognise the achievements of innovative and impactful Victorian mid-career cancer researchers, with the presentation of its inaugural 2020 Award for Outstanding Cancer Research.
The prize of $5,000 aims to reinforce cancer research as a career choice by acknowledging the work of an outstanding mid-career researcher who is likely to become part of the next generation of Victoria’s leading cancer researchers.
The flexible program is designed to be of interest to PhD students with either a scientific or clinical background, including medical graduates, nursing and allied health specialists.